iRhythm Technologies last week set the terms on its forthcoming initial public offering, saying it plans to float 5.35 million shares priced between $13.00 and $15.00 apiece.
At the midpoint, the IPO would fetch $74.9 million. San Francisco-based iRhythm has said it plans to use the proceeds to expand the commercial and clinical footprint of its Zio wearable cardiac monitor.